Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | CCND2 |
| Upstream (Parents) |
|---|
| (<<) CLEC2B → CCND2 |
| (<<) CSGALNACT2 → CCND2 |
| (<<) CTGF → CCND2 |
| (<<) DDX21 → CCND2 |
| (<<) HDAC5 → CCND2 |
| (<<) IVL → CCND2 |
| (<<) KCTD12 → CCND2 |
| (<<) LYPLA2 → CCND2 |
| (<<) MAP2K3 → CCND2 |
| (<<) NNMT → CCND2 |
| (<<) ROBO3 → CCND2 |
| (<<) RTN3 → CCND2 |
| (<<) STK4 → CCND2 |
| (<<) THY1 → CCND2 |
| (<<) TXNIP → CCND2 |
| Downstream (Children) |
|---|
| CCND2 → BBS1 (>>) |
| CCND2 → BCAR3 (>>) |
| CCND2 → CBL (>>) |
| CCND2 → ELF4 (>>) |
| CCND2 → EWSR1 (>>) |
| CCND2 → GNG4 (>>) |
| CCND2 → GPRIN2 (>>) |
| CCND2 → HK2 (>>) |
| CCND2 → IL1F9 (>>) |
| CCND2 → LIMK1 (>>) |
| CCND2 → MAPK14 (>>) |
| CCND2 → MRAS (>>) |
| CCND2 → OVOL1 (>>) |
| CCND2 → PELO (>>) |
| CCND2 → RAC2 (>>) |
| CCND2 → SPR (>>) |
